Age, race, and repeated prostate-specific antigen (PSA) test use in the National Health Interview Survey

Ethnicity and Disease

Volumn 16, Issue 1, 2006, Pages 244-247

  Ross, Louie E ^a   Uhler, Robert J ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

Age factors; Prostate cancer; Prostate specific antigen; Race; Screening

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; EUROPEAN AMERICAN; HEALTH SURVEY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; RACE DIFFERENCE; UNITED STATES; AGE; BLOOD; CAUCASIAN; COMPARATIVE STUDY; DIAGNOSTIC TEST; MIDDLE AGED; PROSTATE TUMOR; UTILIZATION REVIEW;

ADULT; AFRICAN AMERICANS; AGE FACTORS; AGED; AGED, 80 AND OVER; DIAGNOSTIC TESTS, ROUTINE; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; INTERVIEWS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 33744976093     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. American Cancer Society. Cancer Facts and Figures - 2005. Atlanta, Ga: American Cancer Society; 2005.
2. US Preventive Services Task Force. Guide to Clinical Preventive Services: Periodic Updates. 3rd ed. Rockville, Md: Agency for Healthcare Research and Quality and the US Public Health Service; 2003.
3. Ransohoff DF, Collins MM, Fowler FJ. Why is prostate cancer screening so common when the evidence is so uncertain? A system without negative feedback. Am J Med. 2002;113:663-667.
4. American Urological Association. Prostate specific antigen (PSA) best practice policy. Oncology. 2004;14:267-286.
5. National Guideline Clearinghouse. Guideline synthesis: screening for prostate cancer. Available at: www.guideline.gov. Accessed on: 4/4/03.
6. Fowler FJ, Bin L, Collins MM, et al. Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists. Am J Med. 1998;104:526-532.
7. Potosky AL, Feur EJ, Levin DL. Impact of screening on incidence and mortality of prostate cancer in the United States. Epidemiol Rev. 2001;23:181-186.
8. Demark-Wahnefried W, Strigo T, Conaway M, Brunetti M, Rimer B, Robertson N. Knowledge, beliefs, and prior screening behavior among Blacks and Whites reporting for prostate cancer screening. Adult Urology. 1995;46:346-351.
9. Collins MM, Stafford RS, Barry MJ. Age specific patterns of prostate specific antigen testing among primary care physicians. J Fam Pract. 2000;49:169-172.
10. Steele CB, Miller DS, Maylahn C, Uhler RJ, Baker C. Knowledge, attitudes, and screening practices among older men regarding prostate cancer. Am J Public Health. 2000;90:1595-1600.
11. Hiatt RA, Klabunde C, Breen N, Swan J, Ballard-Barbash R. Cancer screening practices from National Health Interview Surveys: past, present, and future. JNCI. 2002;94:1837-1846.
12. National Center for Health Statistics (NCHS). National Health Interview Survey: NHIS Survey Description. Hyattsville, Md: NCHS; 2001.
13. Ross LE, Breen N, Uhler RJ, Potosky AL, Blackman D. Prostate-specific antigen (PSA) test use reported in the 2000 National Health Interview Survey. Prev Med. 2004;38:732-744.
14. Etzioni R, Berry KM, Legler JM, Shaw P. Prostate-specific antigen testing in Black and White men: an analysis of Medicare claims from 1991-1998. Urology. 2002:59:251-255.
15. Lu-yao G, Stukel TA, Yao SL. Prostate-specific antigen screening in elderly. JNCI. 2003;95:1792-1797.
16. Cooper CP, Merritt TL, Ross LE, John LV, Jorgensen CM. To screen or not to screen, when clinical guidelines disagree: primary care physicians' use of the PSA test. Prev Med. 2004;38:182-191.
17. Guidry JJ, Fagan P, Walker V. Cultural sensitivity and readability of breast and prostate printed cancer education materials targeting African Americans. J Natl Med Assoc. 1998;90:165-169.
18. Weinrich SP, Boyd MD, Bradford D, Mossa MS, Weinrich M. Recruitment of African Americans into prostate cancer screening. Cancer Pract. 1998;6:23-30.
19. Volk RJ, Cass AR. The accuracy of primary care patients' self-reports of prostate-specific antigen testing. Am J Prev Med. 2002;22:56-58.
20. Jordan TR, Price JH, King KA, Masyk T, Bedell AW. The validity of male patients' self-reports regarding prostate cancer screening. Prev Med. 1999;28:297-303.